| Tag | Content |
|---|
EnhancerAtlas ID | HS151-02782 |
Organism | Homo sapiens |
Tissue/cell | OCI-LY1 |
Coordinate | chr12:92899070-92900560 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| IRF1 | MA0050.2 | chr12:92899749-92899770 | TCCCCCTTTCACTTTTTTTTT | + | 6.94 | | Myod1 | MA0499.1 | chr12:92899286-92899299 | AGCAGCTGTTCCT | + | 7.22 | | NFAT5 | MA0606.1 | chr12:92899688-92899698 | AATGGAAAAT | - | 6.02 | | NFATC1 | MA0624.1 | chr12:92899688-92899698 | AATGGAAAAT | - | 6.02 | | NFATC3 | MA0625.1 | chr12:92899688-92899698 | AATGGAAAAT | - | 6.02 | | RREB1 | MA0073.1 | chr12:92899523-92899543 | CGTGCGTGTGTGTTTTGGGG | - | 6.34 | | Tcf12 | MA0521.1 | chr12:92899285-92899296 | CAGCAGCTGTT | - | 6.32 | | ZNF263 | MA0528.1 | chr12:92900011-92900032 | GGTGGAGTGGGGGATGGGGGA | + | 6.05 | | ZNF263 | MA0528.1 | chr12:92899153-92899174 | CCCTTATCCTCCTCCTCTTTC | - | 6.29 | | ZNF263 | MA0528.1 | chr12:92899150-92899171 | CCTCCCTTATCCTCCTCCTCT | - | 7.51 |
|
| | Number of super-enhancer constituents: 9 | ID | Coordinate | Tissue/cell |
| SE_10178 | chr12:92895888-92901470 | CD19_Primary | | SE_10867 | chr12:92893714-92902811 | CD20 | | SE_30633 | chr12:92895797-92901308 | Fetal_Muscle | | SE_32476 | chr12:92893802-92901183 | GM12878 | | SE_58387 | chr12:92824686-92900971 | Ly1 | | SE_58903 | chr12:92824688-92901021 | Ly3 | | SE_61018 | chr12:92825256-92901502 | HBL1 | | SE_61483 | chr12:92825418-92902406 | Toledo | | SE_62251 | chr12:92824473-92901385 | Tonsil |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH12I092501 | chr12 | 92895641 | 92901157 |
|
Enhancer Sequence | TGGGATTACA GGCATGAGCT ACTGCACCCA GCCCCTCTCT TTTATTTTTA AGGGCAGAAA 60
AAGACGAAGT GAGAAAGGAG CCTCCCTTAT CCTCCTCCTC TTTCCCCTCG CAGTCCAGCA 120
TCAAAACACT CATTCTTAGG ATGGAGCAGG GGTGGAAAAG TGCAGGAACA TTAGGCCTTG 180
TCTGTGTATT GGCTCCGTTA GGAGCTATTG TTGCTCAGCA GCTGTTCCTC TTGCTTCTTA 240
GGAAGCCCTG CCTGCAAGTG GGCTGGGGAA CCAGTGTGAC ACTGGCAGCT GGGGGAAGTG 300
GGGAGGAACA TCGAATATTT TTTCACCATG AGAAAGATGG GCTTTGTTTC TCAAAAAAGA 360
ACAGAGATCC TGTTTCTGGG TAGCTGTTAT CAGAAACTGG TTTTAATAAA TACAGTTGGA 420
GAGTGAAAGT AAGAGTGTGT GTGTGTGTGT GCGCGTGCGT GTGTGTTTTG GGGGCGGGGG 480
ATAGAAGAGA AAGAGAACAT AAAGTCACAA CCTACTCAAC CTTTAATCCT TTTTTTAAGG 540
TAGGAAAAGC TGAAAAATTT CAGCCAAATG AAAAGCATAA AGTGGTTGAG AAAGGCTTTA 600
TGACTAAGAG AGGATTGCAA TGGAAAATAC GTAAAAAGAG AAGTTAAACC AGCTGGCTTA 660
TTTAATTTTG ACTCCCCACT CCCCCTTTCA CTTTTTTTTT TACCTTCAGC CTAAACTAGG 720
GAAAAATGTA CTGTGTAAAT ATTCAGTGTT TTTCTTAGTT TTTATCCCTA ACAAAATTTT 780
TTACAGGACT TAGTTTAGTG AATCTCCAGA GACTGGGTGT GAACGTGACT TTTCACCCCT 840
GGGTCACGGG TCACTTCCTG CTTCTTCTTG TAAGTAAAAG CTCTTACTAT TCCATGGGTC 900
TGGCTGTACC CAGAAGTGGG GGTAGGGGTG AGGGATGGGA GGGTGGAGTG GGGGATGGGG 960
GAAAACTCAA TGCCTATTCA TTTCTCACAT TATTTTATTG TCAGGAACAT TTCTCCTCCC 1020
ATACTAAAGA GCTAAATGTC AAACTTCTAT TCCAAAGTAC ATGAATAAAT TAATACATTC 1080
CTAGTGTATG AATTTATTCA TGCATTCAAT AAACATCATC GAAGCACTGT CAATGTACTA 1140
GGCATTGTGT TAAGCACTGG GAAAACAAAG ATAACTAAAA TATATTCCCT GTCTTCTACA 1200
TCTTCAAACA AACAGGAGAG ACAGATTCTA GAACAGTAAT TACAGCAATT ACAGTAAGTA 1260
CTGTGAAAAA AAAAGAGCAA AAAACATGTA ACTCTGCCCA GGAAGGGCAA CGAAGACTTC 1320
CAGGAGGTGG TGGTATTGGA ATTGATTTTT GTGAGCTAAG TAGGAACAAC CAGAAGGCCA 1380
GGAAGAGGAA TGGCATTTCA GACAGAGGGA GTGGCCATGG AAAAACCTTG TTTTCACTTT 1440
GGGTAACGAG CAGTCTTTAA TGTTTTACTC TGACTAGGGT TCTGGGAACT 1490
|
